The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rajangam Kanya since 2021.
This trader's CIK number is 1816676.
At the time of last reporting, Rajangam Kanya was the Pres. & Chief Med. & Dev. Off. of Senti Biosciences, Inc.. (stock ticker symbol SNTI).
Also see all insider trading activities at Senti Biosciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | NKTX | 0 | $0 | 10,000 | $372,800 | 10,000 | $4,100 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | SNTI | 0 | $0 | 1,479 | $6,073 | 0 | $0 |
2. Senti Biosciences, Inc. (SNTI)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-08-05 | NKTX | Sale | 10,000 | 37.28 | 372,800 |
2021-08-05 | NKTX | Option Ex | 10,000 | .41 | 4,100 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-06 | SNTI | Sale | 182 | 4.37 | 795 |
2025-02-04 | SNTI | Sale | 1,297 | 4.07 | 5,278 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rajangam Kanya (Pres. & Chief Med. & Dev. Off. of Senti Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.